Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis-Reference-Cited by-同舟云学术

Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis

Published:2016-10 Issue: Volume:171 Page:18-24
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Cobo-Calvo Álvaro,Figueras Agnes,Bau Laura,Matas Elisabet,Mañé Martínez María Alba,León Isabel,Majòs Carles,Romero-Pinel Lucia,Martínez-Yélamos Sergio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N. Engl. J. Med.,2006

2. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin;Yednock;Nature,1992

3. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N. Engl. J. Med.,2012

4. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy;Plavina;Ann. Neurol.,2014

5. L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients;Schwab;Neurology,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Mediated Immunity in Multiple Sclerosis Patients Who Discontinued Therapy with an Integrin Inhibitor;Annals of Clinical and Experimental Neurology;2024-04-05

2. Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring;Frontiers in Immunology;2020-09-24

3. Clinical Decision-Making in the Management of Multiple Sclerosis;Clinical Neuroimmunology;2019-10-25

4. Circulating EZH2-positive T cells are decreased in multiple sclerosis patients;Journal of Neuroinflammation;2018-10-26

5. The effect of disease modifying therapies on CD62L expression in multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2018-07